CPIG
TMBR

Chicago Partners Investment Group’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Chicago Partners Investment Group’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2
Closed -$2K – 333
2019
Q1 		$2K Hold
2
– – ﹤0.01% 313
2018
Q4 		$4K Sell
2
-1
-33% -$2.37K ﹤0.01% 316
2018
Q3 		$7K Buy
+3
New +$8.67K ﹤0.01% 881

Other funds holding TMBR

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFG
Nadler Financial Group Deerfield, Illinois $1.18B AUM 22.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Chicago Partners Investment Group's TMBR Position: Q2 2019 in Review

Chicago Partners Investment Group sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2019, closing a stake of 2 shares — an estimated $2K sold.

Chicago Partners Investment Group first reported a position in TMBR in Q3 2018 and held it in 3 quarters. The position peaked at $7K in Q3 2018. 14 funds tracked by Wall St. Rank hold TMBR as of Q2 2019.

  • Chicago Partners Investment Group reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Chicago Partners Investment Group sold 2 Timber Pharmaceuticals, Inc. shares in Q2 2019, an estimated $2K.
  • Chicago Partners Investment Group first reported a position in Timber Pharmaceuticals, Inc. in Q3 2018 and held it in 3 quarters.
  • Chicago Partners Investment Group's Timber Pharmaceuticals, Inc. position peaked at $7K in Q3 2018.
  • 14 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2019.

Based on Chicago Partners Investment Group's 13F filing for Q2 2019, filed 24 Jul 2019.